PERFECT MEDICAL (01830) announced its interim results with a profit attributable to equity holders of HK$94.8 million, representing a year-on-year decrease of 32.7%.
Perfect Medical (01830) announced its interim performance for the six months ended September 30, 2025. The revenue decreased by 21.7% year-on-year to HKD 486 million, and the attributable profit to equity holders of the company was HKD 94.8 million, down 32.7% year-on-year. The basic earnings per share were 7.5 HK cents, and the recommended interim dividend was 7.6 HK cents per share.
PERFECT MEDICAL (01830) announced its interim results for the six months ended September 30, 2025, with a year-on-year decrease in revenue of 21.7% to HK$486 million. The attributable profit to equity holders of the company was HK$94.8 million, down 32.7% year-on-year. Basic earnings per share were 7.5 HK cents, and a recommended interim dividend of 7.6 HK cents per share.
Related Articles

WUXI LIFE (08148) appoints Yan Dandan as a non-executive director.

KS SMART MGMT (08181) released its interim performance result, with a net loss attributable to shareholders of HKD 29.3 million, representing an increase of approximately 537% year-on-year.

CHONG FAI JEWEL (08537) announces mid-year results with a net profit of HK$3.617 million, a year-on-year increase of approximately 9.36 times.
WUXI LIFE (08148) appoints Yan Dandan as a non-executive director.

KS SMART MGMT (08181) released its interim performance result, with a net loss attributable to shareholders of HKD 29.3 million, representing an increase of approximately 537% year-on-year.

CHONG FAI JEWEL (08537) announces mid-year results with a net profit of HK$3.617 million, a year-on-year increase of approximately 9.36 times.

RECOMMEND

Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025

Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025

Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025


